semaglutide category Effects of Once-Weekly on Kidney Disease Outcomes by KDIGO Risk in the SUSTAIN 6 Trial Semaglutide – Aspire Weight Loss

Discussion This observational cohort study describes real-world utilization patterns and characteristics of patients dispensed an SGLT2i or GLP-1 RA in the US using data from Optum CDM in the period following changes to the landscape for treatment and prevention of CKD in type 2 diabetes (later period, July 2021September 2023) as well as temporal changes in utilization and baseline characteristics relative to the period prior (earlier period, January 2012June 2021)

It's a great way to differentiate in a crowded market

Gynaecol Perinatol

A 2023 observational study published in a peer-reviewed endocrinology journal noted that patients on GLP-1 therapy reported subjective improvements in sleep quality and stress tolerance, metrics often impaired by cortisol dysregulation